Shanwei Xinshangren Cultural Communication Co., Ltd. – Trademark Portfolio
Entity Type: 99
Shanwei Xinshangren Cultural Communication Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include NEXTGENLAB. The owner is based in Shanwei City.
Heshunshang Village,
No. 9, Yanzhu 5th Lane
Shanwei City 516600 , CN
Showing of trademarks Trademarks
Trademark Classifications
Shanwei Xinshangren Cultural Communication Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Shanwei Xinshangren Cultural Communication Co., Ltd. have?
Shanwei Xinshangren Cultural Communication Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Shanwei Xinshangren Cultural Communication Co., Ltd. file in?
Shanwei Xinshangren Cultural Communication Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 9 (Computers & Electronics). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Shanwei Xinshangren Cultural Communication Co., Ltd.'s most well-known trademarks?
Shanwei Xinshangren Cultural Communication Co., Ltd.'s registered trademark portfolio includes well-known marks such as NEXTGENLAB. These are among 1 currently registered trademark in the portfolio.
What is Shanwei Xinshangren Cultural Communication Co., Ltd.'s trademark registration success rate?
Shanwei Xinshangren Cultural Communication Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.